Melanocortin Agonists Enhance Oxytocin's Role in Social Bonding

The neuropeptide oxytocin is a critical regulator of social behaviors and is essential for forming strong social bonds, particularly in monogamous species like the prairie vole. Dysregulation of oxytocin pathways is implicated in various social deficits, including those observed in autism spectrum disorder and schizophrenia. However, the precise mechanisms by which other neuromodulators interact with oxytocin to influence complex social behaviors like partner preference formation remain incompletely understood, and this study specifically investigated how melanocortin receptor activation influences oxytocin's ability to promote social bonding.

Administration of the melanocortin receptor agonist alone did not significantly induce partner preference compared to vehicle-treated controls (p>0.05). However, co-administration of the melanocortin receptor agonist with oxytocin significantly enhanced partner preference formation beyond the effects of oxytocin alone. > Voles treated with both the melanocortin receptor agonist and oxytocin spent 65% of their time with the partner, representing a 2.3-fold increase in preference compared to the oxytocin-only group (p<0.001), which spent 28% of their time with the partner. This synergistic effect was observed to be dose-dependent, with the 0.1 mg/kg MTII dose showing the most robust enhancement. Further analysis revealed that the melanocortin receptor agonist treatment increased the density of oxytocin receptors in key brain regions involved in social bonding, such as the nucleus accumbens, by approximately 35% (p<0.01).